Cumberland Pharmaceu (CPIX) Stock Price, Quote & News

Company Profile

Cumberland Pharmaceuticals Inc., a specialty pharmaceutical company, focuses on the acquisition, development, and commercialization of prescription products for hospital acute care, gastroenterology, and oncology in the United States and internationally. The company offers Acetadote, an injection for the treatment of acetaminophen poisoning; Caldolor, an injection for the treatment of pain and fever; Kristalose, a prescription laxative oral solution for the treatment of constipation; Sancuso, an...

Industry: Drug Manufacturers - Specialty & Generic

Sector: Healthcare

Phone: 615 255 0068

Fax: 615 255 0094

Website: www.cumberlandpharma.com

Address:

1600 West End Avenue, Suite 1300, Nashville, United States

YoloAlfred Oct. 3 at 9:30 PM

$CPIX yep all three of them Kenneth got the most..over 2k shares

1 · Reply

2pumps1dump Oct. 3 at 9:00 PM

$CPIX more insider buys?

0 · Reply

YoloAlfred Oct. 3 at 3:38 PM

$CPIX Have a Great Weekend people......do your research...." Know what you own,and know why you own it"

0 · Reply

YoloAlfred Oct. 3 at 3:26 PM

$CPIX https://beyondspx.com/quote/CPIX/cumberland-pharmaceuticals-specialty-portfolio-and-pipeline-drive-growth-momentum-nasdaq-cpix. For the new investors

0 · Reply

YoloAlfred Oct. 3 at 2:46 PM

$CPIX Solid company 6 fda passed drugs bringing in revenue, ceo owns 40% + of outstanding shares....Izzy from Millenium Management has 800k shares....try and slap 100k shares MARKET ORDER....and stock will halt

0 · Reply

YoloAlfred Oct. 3 at 2:37 PM

$CPIX fintel is showing 27.16% Institutional. ......

0 · Reply

BioResearcher Oct. 3 at 2:31 PM

$CPIX CPIX's drug not only can maintain but also improve the LVEF of DMD patients over time. The improvement (+1.8 from the baseline) is a pleasant surprise for Management, that is why the CEO calls it a breakthrough. In the Fight DMD Trial, their goal is just "NO CHANGE" from the baseline. That mean they expected "zero" from baseline, but the result show "+1.8%" !!! Be patient, folks. I agree with the CEO: this drug is a breakthrough in treating the deadly DMD Cardiomyopathy.

0 · Reply

YoloAlfred Oct. 3 at 2:27 PM

$ANRO ......$CPIX next.....its a buy and hold next 4 weeks play.....4X minimum

0 · Reply

YoloAlfred Oct. 3 at 1:29 PM

$ANRO $ESPR,$CPIX....all bullish.....Looking for Accelerated Approval ($CPIX) under 500k tradable shares....some days only 200k

0 · Reply

HouseOfTheDragons Oct. 3 at 2:58 AM

Looks like volume & momentum could be shifting in to ASTC! Tiny float getting a lot of attention and could explode upwards on volume. Watchers on ASTC are growing very fast and it could be the potential top runner for this week! Starting its 300% run - keep it on watch! Also watching for breakout: $CAPT $QNTM $CPIX $LXEH nx

0 · Reply

CUMBERLAND PHARMACEUTICALS ANNOUNCES PRODUCT APPROVAL IN MEXICO

Sep 29, 2025, 9:05 AM EDT - 5 days ago

TABUK LAUNCHES VIBATIV® FDA-APPROVED ANTIBIOTIC WITH LIFE-SAVING POTENTIAL IN SAUDI ARABIA

Aug 6, 2025, 1:52 AM EDT - 2 months ago

Cumberland Pharmaceuticals Inc. (CPIX) Q2 2025 Earnings Call Transcript

Aug 5, 2025, 4:05 PM EDT - 2 months ago

Cumberland Pharmaceuticals Reports 23% Revenue Growth Year-to-Date

Aug 4, 2025, 9:05 AM EDT - 2 months ago

CUMBERLAND PHARMACEUTICALS RECEIVES VIZIENT CONTRACT FOR NEW VIBATIV® 4-VIAL STARTER PAK

Jul 29, 2025, 4:05 PM EDT - 2 months ago

CUMBERLAND PHARMACEUTICALS TO ANNOUNCE Q2 2025 FINANCIAL RESULTS & COMPANY UPDATE

Jun 23, 2025, 9:05 AM EDT - 3 months ago

Cumberland Pharmaceuticals Shares Phase 2 FIGHT DMD Trial Results at the Parent Project Muscular Dystrophy Annual Conference

May 27, 2025, 4:05 PM EDT - 4 months ago

NEW STUDY FINDS CALDOLOR® SAFE AND EFFECTIVE FOR OPIOID-SPARING PAIN MANAGEMENT IN OLDER ADULTS

May 13, 2025, 4:05 PM EDT - 5 months ago

CUMBERLAND PHARMACEUTICALS PARTNERS WITH QUREIGHT TO ADVANCE INNOVATIVE IDIOPATHIC PULMONARY FIBROSIS TREATMENT RESEARCH

May 10, 2025, 4:23 AM EDT - 5 months ago

Cumberland Pharmaceuticals, Inc. (CPIX) Q1 2025 Earnings Call Transcript

May 6, 2025, 4:05 PM EDT - 5 months ago

Cumberland Pharmaceuticals Reports 38% Revenue Growth in Q1 2025

Apr 29, 2025, 4:05 PM EDT - 5 months ago

CUMBERLAND PHARMACEUTICALS TO ANNOUNCE Q1 2025 FINANCIAL RESULTS & COMPANY UPDATE

Mar 19, 2025, 4:05 PM EDT - 7 months ago

FIGHT DMD Trial Results Selected for Late-Breaking Presentation at MDA Clinical & Scientific Conference

Mar 4, 2025, 7:14 PM EST - 7 months ago

Cumberland Pharmaceuticals Inc. (CPIX) Q4 2024 Earnings Call Transcript

Mar 4, 2025, 4:05 PM EST - 7 months ago

Cumberland Pharmaceuticals Reports 11.6% Fourth Quarter 2024 Revenue Growth

Feb 25, 2025, 4:05 PM EST - 7 months ago

CUMBERLAND PHARMACEUTICALS TO ANNOUNCE ANNUAL 2024 FINANCIAL RESULTS

Feb 18, 2025, 7:30 AM EST - 8 months ago

VIBATIV® RECEIVES MARKETING APPROVAL IN CHINA

Feb 4, 2025, 1:31 PM EST - 8 months ago

Cumberland Pharmaceuticals' Duchenne Candidate Shows Improved Heart Function In Patients With Associated Heart Disease

Feb 4, 2025, 7:30 AM EST - 8 months ago

Cumberland Pharmaceuticals Announces Breakthrough Results from the Phase 2 FIGHT DMD Trial in Duchenne Muscular Dystrophy Heart Disease

Dec 10, 2024, 12:08 PM EST - 10 months ago

Why Is Cumberland Pharmaceuticals Stock Trading Over 100% on Tuesday?

Dec 9, 2024, 4:05 PM EST - 10 months ago

FDA APPROVES ACETADOTE® sNDA

Nov 9, 2024, 1:17 PM EST - 11 months ago

Cumberland Pharmaceuticals Inc. (CPIX) Q3 2024 Earnings Call Transcript

Nov 7, 2024, 4:05 PM EST - 11 months ago

Cumberland Pharmaceuticals Reports Third Quarter 2024 Financial Results and Company Update

Nov 6, 2024, 5:21 PM EST - 11 months ago

CUMBERLAND PHARMACEUTICALS RECEIVES FDA ORPHAN DRUG AND RARE PEDIATRIC DISEASE DESIGNATIONS FOR NEW TREATMENT OF DUCHENNE MUSCULAR DYSTROPHY

Nov 5, 2024, 4:05 PM EST - 11 months ago

New Study Compares Caldolor® (ibuprofen injection) to ketorolac

Oct 31, 2024, 4:05 PM EDT - 1 year ago

CUMBERLAND PHARMACEUTICALS TO ANNOUNCE THIRD QUARTER 2024 FINANCIAL RESULTS

Aug 11, 2024, 12:47 PM EDT - 1 year ago

Cumberland Pharmaceuticals Inc. (CPIX) Q2 2024 Earnings Call Transcript

Aug 6, 2024, 4:05 PM EDT - 1 year ago

Cumberland Pharmaceuticals Reports 16% Sequential Revenue Growth in Second Quarter 2024

Jul 30, 2024, 4:05 PM EDT - 1 year ago

CUMBERLAND PHARMACEUTICALS TO ANNOUNCE SECOND QUARTER 2024 FINANCIAL RESULTS

May 11, 2024, 11:51 PM EDT - 1 year ago

Cumberland Pharmaceuticals Inc. (CPIX) Q1 2024 Earnings Call Transcript

May 7, 2024, 4:05 PM EDT - 1 year ago

Cumberland Pharmaceuticals Reports First Quarter 2024 Financial Results & Company Update

Apr 30, 2024, 4:05 PM EDT - 1 year ago

CUMBERLAND PHARMACEUTICALS TO ANNOUNCE FIRST QUARTER 2024 FINANCIAL RESULTS

Apr 2, 2024, 4:05 PM EDT - 1 year ago

NEW REPORT SUPPORTS USE OF CALDOLOR® AS A STANDARD OF CARE ACROSS PATIENT POPULATIONS

Mar 5, 2024, 10:06 PM EST - 1 year ago

Cumberland Pharmaceuticals Inc. (CPIX) Q4 2023 Earnings Call Transcript

Mar 5, 2024, 4:05 PM EST - 1 year ago

Cumberland Pharmaceuticals Reports Annual 2023 Financial Results

Feb 27, 2024, 4:05 PM EST - 1 year ago

CUMBERLAND PHARMACEUTICALS TO ANNOUNCE ANNUAL 2023 FINANCIAL RESULTS

Nov 11, 2023, 8:17 AM EST - 2 years ago

Cumberland Pharmaceuticals Inc. (CPIX) Q3 2023 Earnings Call Transcript

Nov 7, 2023, 4:05 PM EST - 2 years ago

Cumberland Pharmaceuticals Reports Third Quarter 2023 Financial Results

Oct 31, 2023, 4:05 PM EDT - 2 years ago

CUMBERLAND PHARMACEUTICALS TO ANNOUNCE THIRD QUARTER 2023 FINANCIAL RESULTS

Oct 10, 2023, 4:05 PM EDT - 2 years ago

NEW VIBATV® PEDIATRIC PUBLICATION HIGHLIGHTS ITS SAFETY IN PATIENTS 2 TO 17 YEARS OF AGE

Aug 12, 2023, 4:21 AM EDT - 2 years ago

Cumberland Pharmaceuticals Inc. (CPIX) Q2 2023 Earnings Call Transcript

Aug 8, 2023, 4:05 PM EDT - 2 years ago

Cumberland Pharmaceuticals Reports Revenue and Earnings Growth Second Quarter 2023

Aug 1, 2023, 4:05 PM EDT - 2 years ago

CUMBERLAND PHARMACEUTICALS TO ANNOUNCE SECOND QUARTER 2023 FINANCIAL RESULTS

Jun 26, 2023, 9:00 AM EDT - 2 years ago

NEW PUBLICATION SUPPORTS THE USE OF CALDOLOR® IN NEWBORN PEDIATRIC PATIENTS

May 23, 2023, 9:00 AM EDT - 2 years ago

CUMBERLAND PHARMACEUTICALS ANNOUNCES FDA CLEARANCE OF IND FOR NEW TREATMENT OF IDIOPATHIC PULMONARY FIBROSIS

May 15, 2023, 9:00 AM EDT - 2 years ago

CALDOLOR® NOW FDA APPROVED FOR TREATMENT OF FEVER & PAIN IN INFANTS

May 13, 2023, 5:45 PM EDT - 2 years ago

Cumberland Pharmaceuticals Inc. (CPIX) Q1 2023 Earnings Call Transcript

May 9, 2023, 4:05 PM EDT - 2 years ago

Cumberland Pharmaceuticals Reports First Quarter 2023 Financial Results & Company Update

May 2, 2023, 4:05 PM EDT - 2 years ago

CUMBERLAND PHARMACEUTICALS TO ANNOUNCE FIRST QUARTER 2023 FINANCIAL RESULTS

Mar 7, 2023, 10:47 PM EST - 2 years ago

Cumberland Pharmaceuticals Inc. (CPIX) Q4 2022 Earnings Call Transcript

YoloAlfred Oct. 3 at 9:30 PM

$CPIX yep all three of them Kenneth got the most..over 2k shares

1 · Reply

2pumps1dump Oct. 3 at 9:00 PM

$CPIX more insider buys?

0 · Reply

YoloAlfred Oct. 3 at 3:38 PM

$CPIX Have a Great Weekend people......do your research...." Know what you own,and know why you own it"

0 · Reply

YoloAlfred Oct. 3 at 3:26 PM

$CPIX https://beyondspx.com/quote/CPIX/cumberland-pharmaceuticals-specialty-portfolio-and-pipeline-drive-growth-momentum-nasdaq-cpix. For the new investors

0 · Reply

YoloAlfred Oct. 3 at 2:46 PM

0 · Reply

YoloAlfred Oct. 3 at 2:37 PM

$CPIX fintel is showing 27.16% Institutional. ......

0 · Reply

BioResearcher Oct. 3 at 2:31 PM

0 · Reply

YoloAlfred Oct. 3 at 2:27 PM

$ANRO ......$CPIX next.....its a buy and hold next 4 weeks play.....4X minimum

0 · Reply

YoloAlfred Oct. 3 at 1:29 PM

$ANRO $ESPR,$CPIX....all bullish.....Looking for Accelerated Approval ($CPIX) under 500k tradable shares....some days only 200k

0 · Reply

HouseOfTheDragons Oct. 3 at 2:58 AM

0 · Reply

haha1978 Oct. 2 at 10:00 PM

$CPIX weekly chart reset similar to December.

0 · Reply

YoloAlfred Oct. 2 at 9:29 PM

$CPIX

1 · Reply

YoloAlfred Oct. 2 at 5:11 PM

$CPIX alped 2,000 shares

0 · Reply

haha1978 Oct. 1 at 8:00 PM

$CPIX The sooner management puts it out the better. Expecting a 4x time pop!!!!! Look at that manipulation 500 sell at 3.12. so predictable. They dont have the shares.

0 · Reply

haha1978 Oct. 1 at 7:58 PM

$CPIX Watching the algorithm push it down on 500 shares is crazy. Its been doing this for the last 4 weeks. Still trying to accumulate shares. Time is running out for it. That phase 2 extended data is almost anyday now.

0 · Reply

YoloAlfred Oct. 1 at 11:54 AM

$CPIX News might be coming today

0 · Reply

Baazigar30 Sep. 30 at 9:56 PM

$CPIX 5th one 😂

1 · Reply

Baazigar30 Sep. 30 at 9:55 PM

$CPIX Since yesterday trying to buy some cheap shares ; but no one selling ; Still Watching for entry before run.

1 · Reply

YoloAlfred Sep. 30 at 1:49 PM

$CPIX https://beyondspx.com/quote/CPIX/cumberland-pharmaceuticals-specialty-portfolio-and-pipeline-drive-growth-momentum-nasdaq-cpix

1 · Reply

YoloAlfred Sep. 30 at 12:18 PM

$CPIX odds

0 · Reply

ripztrip Sep. 30 at 3:55 AM

$CPIX garbage

1 · Reply

jiggs10 Sep. 29 at 9:44 PM

$CPIX Anonymity, And an anomaly all in one here.

0 · Reply

Market Cap	46.83M
Revenue (ttm)	37.87M
Net Income (ttm)	-6.48M
EPS (ttm)	N/A
PE Ratio	29.45
Forward PE	N/A
Profit Margin	-17.11%
Debt to Equity Ratio	0.19

Volume	18,200
Avg Vol	47,722
Day's Range	N/A - N/A
Shares Out	14.96M
Stochastic %K	53%
Beta	-0.41
Analysts	Strong Buy
Price Target	$8.50